Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma - Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- April 2015
- DOI:
- 10.1371/journal.pone.0125028
- Bibcode:
- 2015PLoSO..1025028A